MCMarta Chamera

Marta Chamera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Chamera has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vascular Endothelial Function, Carotid Intima–Media Thickness and Coronary Artery Calcification in Women

    by Maciej Koźlik, Marta Chamera, Jonasz Osiecki, Anna Kaźmierska, Jakub Kufel, Iga Paszkiewicz, Marta Bujak, Szymon Ładziński, Maciej Kaźmierski

    Background: Atherosclerosis is a degenerative-proliferative disease that leads to lesions primarily in the tunica intima and media of the arteries. Atherosclerotic plaques undergo progressive calcification, and the hydroxyapatite deposited within them absorbs X-rays. The coronary artery calcification score (CAC-score) can be assessed using computed tomography. Intima–media thickness (IMT) and endothelial function, evaluated by flow-mediated dilatation (FMD) of the brachial artery, can be measured using ultrasound. This study aimed to assess the relationship between CAC-score, atherosclerosis risk factors, IMT, and FMD in women, with particular emphasis on the comparison of IMT measurement sites. Methods: The study included 124 women divided into three groups based on CAC-score. The following parameters were evaluated: risk factors for coronary artery disease (CAD), FMD, and IMT. CAD risk factors included age, BMI, smoking status, hypertension, diabetes, and lipid disorders, which were obtained from medical history. Results: A significant positive correlation was observed between CAC-score and IMT of the common carotid artery in women. IMT measured at the carotid bifurcation showed the strongest correlation with CAC-score. No correlation was found between CAC-score and endothelial dysfunction assessed by FMD. Conclusions: IMT, particularly when measured at the carotid bifurcation, was associated with CAC-score in women without diagnosed CAD, whereas no association was observed between FMD and CAC-score in this population.

  • Open Access

    Primary Results of the SALAMANDER Registry: A Multicenter Observational Cohort Study

    by Wojciech Wańha, Łukasz Kuźma, Mariusz Kowalewski, Sylwia Iwańczyk, Joanna Grygier, Jan Jeske, Marco Frazzetto, Radosław Litwinowicz, Marian Burysz, Ewa Gaszewska‐Żurek, et al.

    Background: The balance between thromboembolic complications and bleeding risk in anticoagulated patients with atrial fibrillation remains challenging, with left atrial appendage occlusion (LAAO) representing a potential alternative. Our prospective multicenter study aimed to evaluate the feasibility, safety, technical, and procedural outcomes of the contemporary practice of stand‐alone LAAO. Methods: The SALAMANDER (Stand‐Alone Left Atrial Appendage Occlusion for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation Disease) registry is a real‐world, multicenter, observational cohort study conducted at 16 cardiac centers in Europe between 2010 and 2024, evaluating the safety and efficacy of LAAO using contemporary devices. Results: A total of 1660 patients were enrolled, with a median age of 76 (interquartile range, 70–81) years and 38% being women. The median CHA 2 DS 2 ‐VASc score was 4 (interquartile range, 3–5). The most common indication for LAAO was significant bleeding (83.7% of patients), most frequently during treatment with direct oral anticoagulants (68.8%) more than vitamin K antagonists (24.9%). The predominant bleeding sites were the lower (27.9%) and upper (21.7%) gastrointestinal tracts, with 17.4% having a history of hemorrhagic stroke. The most common antithrombotic regimen before the procedure was direct oral anticoagulants (48.9%), while postprocedural therapy most often included dual antiplatelet therapy (50%). The technical success rate was 95.5%, with residual leak (2.2%) and tamponade (1.4%) as the main causes of failure. Procedural success was 90.5%, most often limited by vascular complications (3.7%), periprocedural death (1.1%), and major bleeding (0.7%). Technical and procedural success rates did not differ significantly between the devices used. Conclusions: In this large prospective cohort, technical and procedural success rates were similar across all LAAO devices, suggesting comparable safety and efficacy. Postprocedural therapy typically involves dual antiplatelet therapy, with all patients requiring some pharmacological treatment. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05144958.


  • Open Access

    Remote ECG monitoring as a diagnostic tool for therapeutic strategies after transcatheter aortic valve replacement: rationale and design of the DRAGON-TAVI randomized trial

    by Paulina Lis, Maciej Koźlik, Marta Chamera, Andrzej Kułach, Grzegorz Smolka, Malwina Smolarek, Michał Orszulak, Katarzyna Mizia-Stec, Krzysztof Szydło, Krzysztof Gołba, et al.